Muscarine-like symptoms (nausea, vomiting, diarrhea, sweating, increased bronchial and salivary secretions and bradycardia) often appear with overdosage ( cholinergic crisis ) An important complication that can arise is obstruction of the airway by bronchial secretions Pharmacokinetics: IV and IM administration Rapid renal excretion, resulting in a short duration of action of 5-10 mins Major drug Interactions: Care should be given when administering this drug to patients with symptoms of myasthenic weakness who are also on anticholinesterase drugs Since symptoms of anticholinesterase overdose (cholinergic crisis) may mimic underdosage (myasthenic weakness), their condition may be worsened by the use of this drug Figure 2
New research is focusing on potential applications in metabolic disorders, including type 2 diabetes and metabolic syndrome Epitalon research, pioneered by Dr
This modified isomer is selected for its structural stability and suitability for oral delivery
BPC-157: A Fundamentally Different Compound BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in human gastric juice
The MHCC97-L cells were arrested at G1-G0 phase
Taking 5 minutes to breath deeply
